Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Stuttgart - Delayed Quote EUR

Savara Inc (YB4P.SG)

2.8000
-0.0400
(-1.41%)
As of 8:00:43 AM GMT+2. Market Open.
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Expense
102,399
102,399
59,210
38,043
40,633
Operating Income
-102,399
-102,399
-59,210
-38,043
-40,633
Net Non Operating Interest Income Expense
6,467
6,467
4,436
-88
-2,282
Other Income Expense
51
51
76
-19
-99
Pretax Income
-95,881
-95,881
-54,698
-38,150
-43,014
Net Income Common Stockholders
-95,881
-95,881
-54,698
-38,150
-43,014
Diluted NI Available to Com Stockholders
-95,881
-95,881
-54,698
-38,150
-43,014
Basic EPS
-0.48
-0.48
-0.33
-0.25
-0.32
Diluted EPS
-0.48
-0.48
-0.33
-0.25
-0.32
Basic Average Shares
198,191.9360
198,191.9360
165,204.6520
152,771.8170
133,919.1450
Diluted Average Shares
198,191.9360
198,191.9360
165,204.6520
152,771.8170
133,919.1450
Total Operating Income as Reported
-103,196
-103,196
-60,007
-38,839
-41,477
Total Expenses
102,399
102,399
59,210
38,043
40,633
Net Income from Continuing & Discontinued Operation
-95,881
-95,881
-54,698
-38,150
-43,014
Normalized Income
-95,932
-95,932
-54,774
-38,131
-42,915
Interest Income
6,467
6,467
4,436
--
--
Interest Expense
--
--
--
88
2,282
Net Interest Income
6,467
6,467
4,436
-88
-2,282
EBIT
-102,399
-102,399
-59,210
-38,043
-40,732
EBITDA
-102,269
-102,269
-59,133
-37,876
-40,365
Reconciled Depreciation
130
130
77
167
367
Net Income from Continuing Operation Net Minority Interest
-95,881
-95,881
-54,698
-38,150
-43,014
Total Unusual Items Excluding Goodwill
51
51
76
-19
-99
Total Unusual Items
51
51
76
-19
-99
Normalized EBITDA
-102,320
-102,320
-59,209
-37,857
-40,266
12/31/2021 - 5/28/2010

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

VM4.F Vanda Pharmaceuticals Inc.
3.7800
-2.07%
 
NVV1.BE Novavax Inc
6.50
+15.66%
 
OMGAQ Omega Therapeutics, Inc.
0.0470
+42.42%
 
LVTX LAVA Therapeutics N.V.
1.3600
-1.45%
 
VRAX Virax Biolabs Group Limited
1.0200
+6.34%
 
IMNN Imunon, Inc.
0.8766
+0.53%
 
INZY Inozyme Pharma, Inc.
0.9806
-4.80%
 
IMRX Immuneering Corporation
1.4100
+2.17%
 
TECX Tectonic Therapeutic, Inc.
19.54
+0.26%
 
IMMP Immutep Limited
1.6200
+5.88%